Search clinical trials for: CDA Inhibitor E7727/Decitabine Combination Agent ASTX727
Total 7178 results
-
Roswell Park Cancer InstituteNational Comprehensive Cancer NetworkRecruitingCastration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8United States
-
Astex Pharmaceuticals, Inc.CompletedMyelodysplastic Syndrome | MDSUnited States, Canada
-
M.D. Anderson Cancer CenterGenentech, Inc.; Astex Pharmaceuticals, Inc.RecruitingChronic Myelomonocytic Leukemia | Myelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterRecruitingAcute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingRecurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Recurrent Acute Biphenotypic Leukemia | Refractory Acute Biphenotypic LeukemiaUnited States
-
OHSU Knight Cancer InstituteGenentech, Inc.; Oregon Health and Science University; Taiho Oncology, Inc.RecruitingAcute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
Vanderbilt-Ingram Cancer CenterAstex Pharmaceuticals, Inc.; Forma Therapeutics, Inc.WithdrawnAcute Myeloid Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Astex Pharmaceuticals, Inc.RecruitingChronic Phase Chronic Myelogenous Leukemia | Philadelphia Chromosome Positive | BCR-ABL1 Positive Chronic Myelogenous Leukemia | BCR-ABL1 PositiveUnited States
-
M.D. Anderson Cancer CenterRecruitingAcute Myeloid Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
Astex Pharmaceuticals, Inc.Active, not recruitingMyelodysplastic SyndromesSpain, United States, Belgium, Canada, Germany, Italy
-
M.D. Anderson Cancer CenterRecruitingAcute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States
-
National Cancer Institute (NCI)RecruitingChronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Myelodysplastic Syndrome With Excess Blasts | Myeloproliferative NeoplasmUnited States, Canada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Recruiting
-
M.D. Anderson Cancer CenterNot yet recruitingMyeloproliferative Neoplasm | Myelodysplastic Neoplasm | Pathway Mutant Myelodysplastic SyndromesUnited States
-
M.D. Anderson Cancer CenterSuspendedAcute Myeloid LeukemiaUnited States
-
National Cancer Institute (NCI)RecruitingRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell LymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Primary Central Chondrosarcoma | Unresectable Primary Central Chondrosarcoma | Locally Advanced Unresectable Primary Central ChondrosarcomaUnited States
-
Astex Pharmaceuticals, Inc.CompletedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic LeukemiaUnited States, Canada, Spain, Hungary, Austria, Czechia, France, Germany, Italy, United Kingdom
-
Michael SavonaIncyte Corporation; Astex Pharmaceuticals, Inc.; TheradexRecruiting
-
Astex Pharmaceuticals, Inc.RecruitingAcute Myeloid Leukemia | Myelodysplastic SyndromesSpain, Poland, Bulgaria, Lithuania, Slovakia, Romania
-
Astex Pharmaceuticals, Inc.Enrolling by invitationAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic LeukemiaUnited States, Spain, Canada, Austria, Slovakia, Bulgaria, Hungary
-
Astex Pharmaceuticals, Inc.RecruitingAcute Myeloid Leukemia | Myelodysplastic SyndromesSpain, Poland, Bulgaria, Lithuania, Slovakia, Romania
-
Astex Pharmaceuticals, Inc.Active, not recruitingAcute Myeloid LeukemiaUnited States, Spain, Canada
-
Case Comprehensive Cancer CenterNot yet recruitingHead and Neck Squamous Cell Carcinoma | Recurrent Squamous Cell Carcinoma of the Head and Neck | Metastatic Squamous Cell CarcinomaUnited States
-
National Cancer Institute (NCI)SuspendedAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic Triple-Negative Breast Carcinoma | Unresectable Triple-Negative Breast CarcinomaUnited States
-
Massachusetts General HospitalAstex Pharmaceuticals, Inc.Recruiting
-
Otsuka Pharmaceutical Co., Ltd.Active, not recruitingLower-risk MyelodysplasticJapan
-
Memorial Sloan Kettering Cancer CenterAstex Pharmaceuticals, Inc.RecruitingMalignant Peripheral Nerve Sheath Tumors (MPNST)United States
-
Astex Pharmaceuticals, Inc.CompletedAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic LeukemiaUnited States
-
Kathy MillerPfizer; Astex Pharmaceuticals, Inc.; Van Andel Institute Stand Up to Cancer TeamCompletedMetastatic Breast Cancer | Triple Negative Breast Cancer | Hormone Receptor Positive TumorUnited States
-
National Cancer Institute (NCI)Active, not recruitingAcute Myeloid LeukemiaUnited States
-
Astex Pharmaceuticals, Inc.TerminatedAcute Myeloid LeukemiaUnited States
-
Groupe Francophone des MyelodysplasiesAstex Pharmaceuticals, Inc.Active, not recruiting
-
M.D. Anderson Cancer CenterAstex Pharmaceuticals, Inc.Not yet recruitingAllogeneic Stem Cell TransplantationUnited States
-
M.D. Anderson Cancer CenterAstex Pharmaceuticals, Inc.; Syndax PharmaceuticalsRecruiting
-
Astex Pharmaceuticals, Inc.Active, not recruitingRelapsed/Refractory Peripheral T-cell LymphomaSpain, United States, Australia, France, United Kingdom, Italy, Poland
-
Royal Marsden NHS Foundation TrustMerck Sharp & Dohme LLC; Astex Pharmaceuticals, Inc.; Institute of Cancer Research...RecruitingNon Small Cell Lung Cancer | Castration-Resistant Prostatic CancerUnited Kingdom
-
Pamela MunsterNational Cancer Institute (NCI)RecruitingBRCA1 Mutation | BRCA2 Mutation | PALB2 Gene Mutation | ATM Gene Mutation | BRCA Mutation | Checkpoint Kinase 2 Gene MutationUnited States
-
Washington University School of MedicineTaiho Oncology, Inc.RecruitingMyelodysplastic SyndromesUnited States
-
M.D. Anderson Cancer CenterAstex Pharmaceuticals, Inc.SuspendedAcute Myeloid LeukemiaUnited States
-
Astex Pharmaceuticals, Inc.TerminatedMyelodysplastic SyndromesUnited States
-
Clinical Hub for Interventional Research (CHOIR)The University of New South Wales; Australian National UniversityRecruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Chronic Myelomonocytic LeukemiaAustralia
-
Imperial College LondonAdvanced Accelerator Applications International SARecruiting
-
Race Oncology LtdAstex Pharmaceuticals, Inc.WithdrawnAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Higher Risk Myelodysplastic SyndromeAustralia
-
Otsuka Beijing Research InstituteRecruitingMyelodysplastic SyndromesChina
-
The First Affiliated Hospital of Soochow UniversityRecruitingAcute Myeloid Leukemia, AdultChina
-
Bio-Path Holdings, Inc.RecruitingAcute Myeloid Leukemia (AML)United States
-
University of KansasNovartisCompletedAcute Myeloid LeukemiaUnited States
-
Karyopharm Therapeutics IncActive, not recruitingAcute Myeloid Leukemia (AML) | Metastatic Colorectal Cancer (mCRC) | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Relapsed/Refractory Multiple Myeloma (RRMM) | Higher-Risk Myelodysplastic Syndrome (HR-MDS) | Newly Diagnosed Intermediate/High-Risk MDSUnited States, France, Canada, Spain, China
-
University of Colorado, DenverNational Comprehensive Cancer Network; Taiho Oncology, Inc.RecruitingMalignant MelanomaUnited States